Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
Chikako Ichikawa,1 Sho Tanaka,2,3 Masahiro Takubo,1,3 Masaru Kushimoto,3 Jin Ikeda,3 Katsuhiko Ogawa,3,4 Ichiro Tsujino,3,5 Yutaka Suzuki,3,4 Masanori Abe,2 Hisamitsu Ishihara,1 Midori Fujishiro1,3 1Division of Diabetes and Metabolic Diseases, Department of Internal Medicine, Nihon University School...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4f31dc3b9e4d4e1ea817d74633399601 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4f31dc3b9e4d4e1ea817d74633399601 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4f31dc3b9e4d4e1ea817d746333996012021-12-02T14:57:41ZTuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus1178-203Xhttps://doaj.org/article/4f31dc3b9e4d4e1ea817d746333996012021-05-01T00:00:00Zhttps://www.dovepress.com/tuberculosis-relapse-in-the-epididymis-after-the-completion-of-nine-mo-peer-reviewed-fulltext-article-TCRMhttps://doaj.org/toc/1178-203XChikako Ichikawa,1 Sho Tanaka,2,3 Masahiro Takubo,1,3 Masaru Kushimoto,3 Jin Ikeda,3 Katsuhiko Ogawa,3,4 Ichiro Tsujino,3,5 Yutaka Suzuki,3,4 Masanori Abe,2 Hisamitsu Ishihara,1 Midori Fujishiro1,3 1Division of Diabetes and Metabolic Diseases, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan; 2Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan; 3Department of Internal Medicine, Nihon University Hospital, Tokyo, Japan; 4Division of Neurology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan; 5Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, JapanCorrespondence: Sho TanakaDivision of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, JapanTel +81-3-3972-8111Fax +81-3-3972-8311Email tanakasho13@gmail.comMidori FujishiroDivision of Diabetes and Metabolic Diseases Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, JapanTel +81-3-3972-8111Fax +81-3-3972-8199Email fujishiro.midori@nihon-u.ac.jpAbstract: The standard six-month tuberculosis (TB) treatment comprises an intensive phase lasting two months, followed by a continuation phase lasting four months. Meanwhile, the nine-month regimen, which has a prolonged continuation phase, is indicated for patients with complicated diabetes mellitus (DM) because of their poor response to treatment. A 61-year-old Japanese man with poorly controlled DM for five years presented with bilateral scrotal swelling noticed two weeks ago. He had a history of pleuritis, pericarditis, and peritonitis two years ago. These symptoms led to the diagnosis of culture-negative extrapulmonary TB. He received the nine-month chemotherapy regimen (isoniazid, rifampin, pyrazinamide, and ethambutol for two months, followed by isoniazid and rifampin for seven months), and his symptoms significantly improved. The swollen scrotum was accompanied by mild tenderness and pus discharge from a fistula. Imaging study revealed bilaterally diffusely enlarged epididymis. However, the acid-fast bacilli smear and culture and polymerase chain reaction using urine and pus discharge tested negative. Bilateral epididymectomy was performed. Although the acid-fast bacilli smear was negative, the pathology demonstrated granuloma formation and acid-fast bacilli tissue culture confirmed multi-drug resistant Mycobacterium tuberculosis. The optimal treatment regimen and duration for extrapulmonary TB with unknown drug susceptibility are debatable. The nine-month regimen can be insufficient in some cases. Thus, detailed follow-up is essential, and TB relapse should be thoroughly monitored.Keywords: chemotherapy, diabetes mellitus, tuberculosis, epididymitisIchikawa CTanaka STakubo MKushimoto MIkeda JOgawa KTsujino ISuzuki YAbe MIshihara HFujishiro MDove Medical Pressarticlechemotherapydiabetes mellitustuberculosisepididymitisTherapeutics. PharmacologyRM1-950ENTherapeutics and Clinical Risk Management, Vol Volume 17, Pp 463-470 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
chemotherapy diabetes mellitus tuberculosis epididymitis Therapeutics. Pharmacology RM1-950 |
| spellingShingle |
chemotherapy diabetes mellitus tuberculosis epididymitis Therapeutics. Pharmacology RM1-950 Ichikawa C Tanaka S Takubo M Kushimoto M Ikeda J Ogawa K Tsujino I Suzuki Y Abe M Ishihara H Fujishiro M Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus |
| description |
Chikako Ichikawa,1 Sho Tanaka,2,3 Masahiro Takubo,1,3 Masaru Kushimoto,3 Jin Ikeda,3 Katsuhiko Ogawa,3,4 Ichiro Tsujino,3,5 Yutaka Suzuki,3,4 Masanori Abe,2 Hisamitsu Ishihara,1 Midori Fujishiro1,3 1Division of Diabetes and Metabolic Diseases, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan; 2Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan; 3Department of Internal Medicine, Nihon University Hospital, Tokyo, Japan; 4Division of Neurology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan; 5Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, JapanCorrespondence: Sho TanakaDivision of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, JapanTel +81-3-3972-8111Fax +81-3-3972-8311Email tanakasho13@gmail.comMidori FujishiroDivision of Diabetes and Metabolic Diseases Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, JapanTel +81-3-3972-8111Fax +81-3-3972-8199Email fujishiro.midori@nihon-u.ac.jpAbstract: The standard six-month tuberculosis (TB) treatment comprises an intensive phase lasting two months, followed by a continuation phase lasting four months. Meanwhile, the nine-month regimen, which has a prolonged continuation phase, is indicated for patients with complicated diabetes mellitus (DM) because of their poor response to treatment. A 61-year-old Japanese man with poorly controlled DM for five years presented with bilateral scrotal swelling noticed two weeks ago. He had a history of pleuritis, pericarditis, and peritonitis two years ago. These symptoms led to the diagnosis of culture-negative extrapulmonary TB. He received the nine-month chemotherapy regimen (isoniazid, rifampin, pyrazinamide, and ethambutol for two months, followed by isoniazid and rifampin for seven months), and his symptoms significantly improved. The swollen scrotum was accompanied by mild tenderness and pus discharge from a fistula. Imaging study revealed bilaterally diffusely enlarged epididymis. However, the acid-fast bacilli smear and culture and polymerase chain reaction using urine and pus discharge tested negative. Bilateral epididymectomy was performed. Although the acid-fast bacilli smear was negative, the pathology demonstrated granuloma formation and acid-fast bacilli tissue culture confirmed multi-drug resistant Mycobacterium tuberculosis. The optimal treatment regimen and duration for extrapulmonary TB with unknown drug susceptibility are debatable. The nine-month regimen can be insufficient in some cases. Thus, detailed follow-up is essential, and TB relapse should be thoroughly monitored.Keywords: chemotherapy, diabetes mellitus, tuberculosis, epididymitis |
| format |
article |
| author |
Ichikawa C Tanaka S Takubo M Kushimoto M Ikeda J Ogawa K Tsujino I Suzuki Y Abe M Ishihara H Fujishiro M |
| author_facet |
Ichikawa C Tanaka S Takubo M Kushimoto M Ikeda J Ogawa K Tsujino I Suzuki Y Abe M Ishihara H Fujishiro M |
| author_sort |
Ichikawa C |
| title |
Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus |
| title_short |
Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus |
| title_full |
Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus |
| title_fullStr |
Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus |
| title_full_unstemmed |
Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus |
| title_sort |
tuberculosis relapse in the epididymis after the completion of nine months of anti-tuberculosis chemotherapy in a patient with poorly controlled diabetes mellitus |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/4f31dc3b9e4d4e1ea817d74633399601 |
| work_keys_str_mv |
AT ichikawac tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus AT tanakas tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus AT takubom tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus AT kushimotom tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus AT ikedaj tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus AT ogawak tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus AT tsujinoi tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus AT suzukiy tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus AT abem tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus AT ishiharah tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus AT fujishirom tuberculosisrelapseintheepididymisafterthecompletionofninemonthsofantituberculosischemotherapyinapatientwithpoorlycontrolleddiabetesmellitus |
| _version_ |
1718389324635963392 |